Comprehensive quantitative analysis of alternative splicing variants reveals the HNF1B mRNA splicing pattern in various tumour and non-tumour tissues
Autor: | Jan Hojny, Romana Michalkova, Eva Krkavcova, Quang Hiep Bui, Michaela Bartu, Kristyna Nemejcova, Marta Kalousova, Petra Kleiblova, Pavel Dundr, Ivana Struzinska |
---|---|
Rok vydání: | 2021 |
Předmět: |
RNA metabolism
Science High-Throughput Nucleotide Sequencing RNA sequencing Polymerase Chain Reaction Article Gene Expression Regulation Neoplastic Alternative Splicing Neoplasms Biomarkers Tumor Reverse transcription polymerase chain reaction Medicine Humans Protein Isoforms RNA Messenger RNA Neoplasm Gene expression Cancer genetics Hepatocyte Nuclear Factor 1-beta Retrospective Studies |
Zdroj: | Scientific Reports Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022) |
ISSN: | 2045-2322 |
Popis: | Hepatocyte nuclear factor-1-beta (HNF1B) is a transcription factor and putative biomarker of solid tumours. Recently, we have revealed a variety of HNF1B mRNA alternative splicing variants (ASVs) with unknown, but potentially regulatory, functions. The aim of our work was to quantify the most common variants and compare their expression in tumour and non-tumour tissues of the large intestine, prostate, and kidney. The HNF1B mRNA variants 3p, Δ7, Δ7–8, and Δ8 were expressed across all the analysed tissues in 28.2–33.5%, 1.5–2%, 0.8–1.7%, and 2.3–6.9% of overall HNF1B mRNA expression, respectively, and occurred individually or in combination. The quantitative changes of ASVs between tumour and non-tumour tissue were observed for the large intestine (3p, Δ7–8), prostate (3p), and kidney samples (Δ7). Decreased expression of the overall HNF1B mRNA in the large intestine and prostate cancer samples compared with the corresponding non-tumour samples was observed (p = 0.019 and p = 0.047, respectively). The decreased mRNA expression correlated with decreased protein expression in large intestine carcinomas (p |
Databáze: | OpenAIRE |
Externí odkaz: |